Properties |
Information |
PhytoCAT-ID |
PhytoCAT-145 |
Phytochemical name or plant extracts |
Eupalinolide O |
PMID |
27666560 |
Literature evidence |
Here, we demonstrated that Eupalinolide O (EO), a novel sesquiterpene lactone isolated from Eupatorium lindleyanum DC., showed significant anticancer activity against human MDA-MB-468 breast cancer cells. |
IUPAC name |
[(3aR,4R,6E,9S,10E,11aR)-9-acetyloxy-6-formyl-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] (E)-4-hydroxy-2-methylbut-2-enoate |
Phytochemicals’ class or type of plant extracts |
Sesquiterpene lactone |
Source of phytochemicals or plant Extracts |
Eupatorium lindleyanum |
|
Geographical availability |
Amur, China North-Central, China South-Central, China Southeast, Hainan, Inner Mongolia, Japan, Khabarovsk, Korea, Manchuria, Myanmar, Nansei-shoto, Philippines, Primorye, Qinghai, Taiwan, Tibet, Vietnam |
Plant parts |
NA |
Other cancers |
Breast cancer |
Target gene or protein |
Cyclin B1, cdc2 |
Gene or Protein evidence |
The expression of cell cycle-related proteins (cyclin B1 and cdc2) was significantly decreased. |
Target pathways |
Akt pathway |
IC50 |
NA |
Potency |
Collectively, EO suppressed the growth of the MDA-MB‑468 cells possibly by cell cycle arrest in the G2/M phase and the induction of caspase-dependent apoptosis. These results suggest that EO is a promising natural compound for breast cancer therapy. |
Cell line/ mice model |
MDA-MB-468 |
Additional information |
Further study demonstrated that EO induced apoptotic cell death in the MDA-MB-468 cells through the activation of caspases.
The effect of EO on the induction of apoptosis was significantly prevented by the treatment of pan-caspase inhibitor Z-VAD-FMK.
We also found that EO treatment resulted in cell cycle arrest in the G2/M phase. |
PubChem ID |
154809464 |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:206259-1 |
Safety |
NA |